Compound Report Overview
          
          
          
          
          
            
              Compound Identifier: 
              703155
            
           
          
          
          
          
          
          
          
          
          
          
          
          
            
              Development Status: 
              Clinical Phase IIIII
            
           
          
          
          
            
              SMILES: 
              CC(O)NC1C(O)C(OC2OC(CO)C(OC3OC(C(OC4OC(CO)C(OC5OC(CO)C(O)C(OC(O)C)C5O)C(OC(O)C)C4O)C(OC(O)C)C3O)C(O)O)C(OC(O)C)C2O)C(CO)OC1OC6C(CO)OC(OC7C(CO)OC(OC8C(CO)OC(O)C(O)C8OC(O)C)C(O)C7OC(O)C)C(O)C6OC(O)C